FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to dermatology and clinical laboratory diagnostics, and can be used to assess the effectiveness of the treatment of trichophytosis in children. On the 10th day of treatment, the content of the immunological indicator in the serum of the venous blood is determined. As an immunological indicator, the content of matrix metalloproteinase-2 is determined. When its value is 5.80 ng/ml and higher, the effectiveness of treatment is assessed as low, less than 5.80 ng/ml - as high.
EFFECT: method makes it possible to simplify the method for assessing the effectiveness of the treatment of trichophytosis in children by examining the level of the laboratory blood index - matrix metalloproteinase-2.
1 cl, 1 tbl, 5 ex
Authors
Dates
2022-02-03—Published
2021-06-01—Filed